PillRx only · Capsule · Oral
Rifabutin
Rifabutin
6 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US7 NDCs
6 active makers
6 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
ATC—
RxCUI (US)—
US makers6 labelers
Packages8
DEA / ScheduleNone
US acquisition costNADAC · per unit
Average across 3 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$8.541
Latest avg · Jul 22, 2026
-8%
Since Dec 17, 2025
6
Active US suppliers
50%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
4.2K
Rx · 2026 Q1
155K
Units dispensed
+10%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it6 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| REMEDYREPACK INC. | repackager | 3 | SUPPLYING |
| i3 Pharmaceuticals, LLC | unknown | 1 | SUPPLYING |
| A2A Integrated Pharmaceuticals | unknown | 1 | SUPPLYING |
| Mylan Pharmaceuticals Inc. | unknown | 1 | SUPPLYING |
| Marlex Pharmaceuticals Inc | unknown | 1 | SUPPLYING |
| ANI Pharmaceuticals, Inc. | unknown | 1 | SUPPLYING |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.